Charles Winter

Technik-/Wissenschafts-/F&E-Leiter bei JANUX THERAPEUTICS, INC.

Vermögen: 3 Mio $ am 31.05.2024

Health Technology

Consumer Services

Aktive Positionen von Charles Winter

Unternehmen	Position	Beginn	Ende
JANUX THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2021	-

Unternehmen	Position	Beginn	Ende
ANAPTYSBIO, INC.	Corporate Officer/Principal	01.08.2020	01.03.2021
SYNTHORX, INC.	Corporate Officer/Principal	01.01.2020	01.08.2020
DENALI THERAPEUTICS INC.	Corporate Officer/Principal	01.11.2016	01.06.2018
JHL BIOTECH, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2015	01.08.2016
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01.09.2011	01.06.2015
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01.01.1994	01.09.2011

University of Wisconsin

Undergraduate Degree

International

Vereinigte Staaten	8
Taiwan	2

Operativ

Corporate Officer/Principal	5
Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1

Sektoral

Health Technology	8
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
GILEAD SCIENCES, INC.	Health Technology
JANUX THERAPEUTICS, INC.	Health Technology
ANAPTYSBIO, INC.	Health Technology
DENALI THERAPEUTICS INC.	Health Technology

Private Unternehmen	3
Eden Biologics, Inc. Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan.	Health Technology
Synthorx, Inc. Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology